Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gavriatopoulou

Showing results (1-10 of 281) with videos related to

Pageof 29
Sort By:
Cancers|January 17, 2020
Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction ToolsDespina Fotiou, Maria Gavriatopoulou, Evangelos Terpos
Metabolism: Clinical and Experimental|November 28, 2017
Biology and treatment of myeloma related bone diseaseEvangelos Terpos, Dimitrios Christoulas, Maria Gavriatopoulou
Expert Opinion on Biological Therapy|January 17, 2020
Antibody therapies for multiple myelomaIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos
Journal of Hematology & Oncology|May 13, 2025
Practice-changing updates on multiple myeloma: highlights from the 2024 ASH annual meetingIoannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou
Oncotargets and Therapy|July 17, 2020
Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient SelectionPanagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Expert Review of Hematology|May 24, 2018
Optimizing therapy in bortezomib-exposed patients with multiple myelomaMagdalini Migkou, Maria Gavriatopoulou, Evangelos Terpos, et al.
Expert Opinion on Pharmacotherapy|September 21, 2016
Current treatments for renal failure due to multiple myelomaMaria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, et al.
Therapeutic Advances in Hematology|May 19, 2022
Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myelomaDespina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, et al.
Expert Review of Hematology|October 5, 2018
Management of multiple myeloma bone disease: impact of treatment on renal functionNikolaos Kanellias, Maria Gavriatopoulou, Evangelos Terpos, et al.
Expert Opinion on Biological Therapy|February 25, 2009
Applications of monoclonal antibodies for the treatment of hematological malignanciesMagda Migkou, Meletios-Athanassios Dimopoulos, Maria Gavriatopoulou, et al.
Pageof 29

Showing results (1-10 of 281) with videos related to

Sort By:
Pageof 29
Cancers|January 17, 2020
Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction ToolsDespina Fotiou, Maria Gavriatopoulou, Evangelos Terpos
Metabolism: Clinical and Experimental|November 28, 2017
Biology and treatment of myeloma related bone diseaseEvangelos Terpos, Dimitrios Christoulas, Maria Gavriatopoulou
Expert Opinion on Biological Therapy|January 17, 2020
Antibody therapies for multiple myelomaIoannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos
Journal of Hematology & Oncology|May 13, 2025
Practice-changing updates on multiple myeloma: highlights from the 2024 ASH annual meetingIoannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Maria Gavriatopoulou
Oncotargets and Therapy|July 17, 2020
Clinical Utility of Selinexor/Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma: A Review of Current Evidence and Patient SelectionPanagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, et al.
Expert Review of Hematology|May 24, 2018
Optimizing therapy in bortezomib-exposed patients with multiple myelomaMagdalini Migkou, Maria Gavriatopoulou, Evangelos Terpos, et al.
Expert Opinion on Pharmacotherapy|September 21, 2016
Current treatments for renal failure due to multiple myelomaMaria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, et al.
Therapeutic Advances in Hematology|May 19, 2022
Pomalidomide- and dexamethasone-based regimens in the treatment of refractory/relapsed multiple myelomaDespina Fotiou, Maria Gavriatopoulou, Evangelos Terpos, et al.
Expert Review of Hematology|October 5, 2018
Management of multiple myeloma bone disease: impact of treatment on renal functionNikolaos Kanellias, Maria Gavriatopoulou, Evangelos Terpos, et al.
Expert Opinion on Biological Therapy|February 25, 2009
Applications of monoclonal antibodies for the treatment of hematological malignanciesMagda Migkou, Meletios-Athanassios Dimopoulos, Maria Gavriatopoulou, et al.
Pageof 29